Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options

The human world is currently influenced largely by the outbreak of pandemic COVID-19. At this moment, most researchers focus on developing treatment strategies and measures to work against COVID-19. Treatment strategies specific for COVID-19 are lacking. This article provides an overview of the life cycle and routes of transmission of SARS-CoV-2. The therapeutic effects of two drugs [i. e., remdesivir (RDV) and favipiravir (FPV)] which can potentially tackle COVID-19 are discussed based on current published data. This review can serve as a reference for future studies.

Automated summary

The article provides an overview of the life cycle and transmission routes of SARS-CoV-2, discussing potential therapeutic effects of two drugs (remdesivir and favipiravir) against COVID-19 based on current data. This review can serve as a reference for future studies.